Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 1998

View Archived Issues

LeukoSite: year-end 1997 highlights

The effects of NPY antagonist BIBP-3226 on blood pressure and heart rate

Cypress Bioscience: Q4 and year-end 1997 highlights

Gilead: Q4 and year-end 1997 highlights

Genome Therapeutics and Schering-Plough expand antiinfectives alliance

Alliance formed for development of oral vaccines from plants

Lilly expands product options for Ligand

FDA advisory panel to review TMR using Heart Laser System

FDA Advisory Committee will meet to discuss Myotrophin

New potassium channel activators from American Home

Japanese academics collaborate in the study of oral platinum complex

SmithKline Beecham claims indolines for CNS disorders

Allergan develops retinoid-like compounds

Antimigraine agent for nasal or oral administration disclosed by Pierre Fabre

Inhibitors of cholesterol biosynthesis under study at Pfizer

New melanoma immunotherapy approaches show clinical potential

First launch for Synthelabo antihistamine

Patient enrollment complete for Gd-Tex phase II trial

FDA approves ocular antiinflammatory agent

Biomatrix and Novartis sign distribution agreement for Synvisc

Novel anti-HIV compound acts by inhibiting HIV-1 transcription

Taylor acquires anesthetic products from Janssen

Polydex receives continuing funding for contraceptive research

Inex finalizes acquisition of Lynx antisense assets

Detrusitol launched in U.K. and Germany

Antitumor TEPA analogue described by Lithuanian researchers

Bone Care International submits NDA for oral one-alpha D2

Crixivan gets traditional FDA approval

Diovan HCT approved in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...